Cite
HARVARD Citation
Torrente-Segarra, V. et al. (2016). RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database. Modern rheumatology. 26 (3), pp. 336-341. [Online].